Efficacy and safety of onasemnogene abeparvovec in children with spinal muscular atrophy type 1: real-world evidence from 6 infusion centres in the United Kingdom
2023 · The Lancet Regional Health - Europe · 34 citations
https://doi.org/10.1016/j.lanepe.2023.100817